Clevudine

克拉夫定

Report date: 2025/08/29 20:01:31
NME

Base Information

Drug NameClevudine
Drug Alias Nameclevudinum克力夫定克来夫定clevudina克立夫定 +[9] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHBV DNA Polymerase inhibitors
TargetsHBV DNA Polymerase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Hepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2006/01/01
Country/TerritoryCanadaUnited StatesSingapore +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBukwang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBukwang Pharmaceutical Co Ltd
Inactive CompaniesTriangle Pharmaceuticals
Active IndicationsCoronavirus Disease 2019 (COVID-19)Hepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ05AF12
Related LinksWikipediaKEGG